Lewes, DE -- (SBWIRE) -- 09/05/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Plandai Biotechnology Inc (OTCMKTS:PLPL), Applied DNA Sciences Inc (OTCBB:APDN), Nutra Pharma Corp. (OTCMKTS:NPHC), STELLAR BIOTECH INC (OTCMKTS: SBOTF)
Plandai Biotechnology Inc (OTCMKTS:PLPL) shares traded down -17.92% during the current trading session, hitting $0.435 recently.
The share price of PLPL is currently trading within the range of $0.41 to $0.53. The company has a market capitalization of $48.24 million, whereas its total outstanding shares are 266,402.00. Company’s beta value stands at 6.85 points. Plandaí Biotechnology, Inc. focuses on the farming of whole fruits, vegetables, and live plant material. It produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa.
Has PLPL Found The Bottom and Ready To Move Up? Find Out Here
Applied DNA Sciences Inc (OTCBB:APDN) shares traded up +0.16% during the current trading session, hitting $0.125 recently. The share price of APDN is currently trading within the range of $0.12 to $0.13. Company’s beta value stands at 1.52 points.
Nokia’s current trading volume is 1.43 million, while its average volume is 3.12 million shares. Last 5 day’s trade of the company shows a negative performance overall, losing -9.93%. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States
For How Long APDN will Fight for Profitability? Read This Trend Analysis report
Nutra Pharma Corp. (OTCMKTS:NPHC) is trading with an upsurge 11.43%, along with the trading price of $0.0234 up till now, while its today’s opening price was $0.02.
NOK recently gained a volume of 10.65 million shares, while its average volume is 6.48 million shares. The 52 week price range of the company is $0.02 - $0.04, while today, up until 1:46PM, its minimum price was $0.02.
Company’s 6 month’s performance gave an optimistic outlook overview as it gained 238.57%. Nutra Pharma Corporation, a biotechnology company, engages in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases.
For How Long NPHC Gloss will Attract Investors? Find out via this report
STELLAR BIOTECH INC (OTCMKTS: SBOTF) stock hit its highest price at $1.24, after starting its trade at $1.21. Company reported an increase of 1.64% at the price of $1.24 recently and its current day range is from $1.17 to $1.24.
Nokia’s total market capitalization remained $66.04 million. Its current volume is 186,833.00 in the early hours of trading, while if we look at its average volume, that is 339,415.00 shares. Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe.
Will SBOTF Continue To Move Higher? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/